Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Jing Wang, Yan Liu, Hongbing Cai, Hong Jiang, Wei Li & Yuying Shi. (2021) Long coding RNA CCAT2 enhances the proliferation and epithelial-mesenchymal transition of cervical carcinoma cells via the microRNA-493-5p/CREB1 axis. Bioengineered 12:1, pages 6264-6274.
Read now
Read now
Shulin Li, Yuqi Wu, Jiawei Zhang, Hao Sun & Xiangwei Wang. (2020) Role of miRNA-424 in Cancers. OncoTargets and Therapy 13, pages 9611-9622.
Read now
Read now
Articles from other publishers (22)
Hayat Miftah, Oumayma Naji, Saadia Ait Ssi, Amina Ghouzlani, Abdelhakim Lakhdar & Abdallah Badou. (2023) NR2F6, a new immune checkpoint that acts as a potential biomarker of immunosuppression and contributes to poor clinical outcome in human glioma. Frontiers in Immunology 14.
Crossref
Crossref
Soudeh Ghafouri-Fard, Arian Askari, Bashdar Mahmud Hussen, Mohammad Taheri & Nader Akbari Dilmaghani. (2023) Role of miR-424 in the carcinogenesis. Clinical and Translational Oncology 26:1, pages 16-38.
Crossref
Crossref
Bianca Oana Pirlog, Silvina Ilut, Radu Pirlog, Paul Chiroi, Andreea Nutu, Delia Ioana Radutiu, George Daniel Cuc, Ioana Berindan-Neagoe, Seyed Fazel Nabavi, Rosanna Filosa & Seyed Mohammad Nabavi. (2023) New perspective on DNA response pathway (DDR) in glioblastoma, focus on classic biomarkers and emerging roles of ncRNAs. Expert Reviews in Molecular Medicine 25.
Crossref
Crossref
João Basso, Ana Fortuna, Rui Vitorino, Nobuyoshi Akimitsu & Carla Vitorino. 2023. New Insights Into Glioblastoma. New Insights Into Glioblastoma
477
504
.
Xuan Wang, Xudong Li, Yan Zhou, Xing Huang & Xiaobing Jiang. (2021) Long non-coding RNA OIP5-AS1 inhibition upregulates microRNA-129-5p to repress resistance to temozolomide in glioblastoma cells via downregulating IGF2BP2. Cell Biology and Toxicology 38:6, pages 963-977.
Crossref
Crossref
Fatemeh Najafi, Shohre Karimi Kelaye, Bahareh Kazemi, Zahra Foruzandeh, Farahnaz Allahverdizadeh, Sajjad Vakili, Kowsar Kiani Rad, Mahdi Derakhshani, Saeed Solali & Mohammad Reza Alivand. (2022) The role of miRNA-424 and miR-631 in various cancers: Focusing on drug resistance and sensitivity. Pathology - Research and Practice 239, pages 154130.
Crossref
Crossref
Yang Zhang, Ying Xiao, Gui-Chen Li, Feng-Yan Gong, Xiao-Na Zhang & Kun Hou. (2022) Long non-coding RNAs as epigenetic mediator and predictor of glioma progression, invasiveness, and prognosis. Seminars in Cancer Biology 83, pages 536-542.
Crossref
Crossref
Sui Li, Xiaofang Xie, Fu Peng, Junrong Du & Cheng Peng. (2022) Regulation of temozolomide resistance via lncRNAs: Clinical and biological properties of lncRNAs in gliomas (Review). International Journal of Oncology 61:3.
Crossref
Crossref
Jianyun Zhou, Xiumei Wang, Yun Han, Qiaoxiang Chu & Yanli Zheng. (2022) lncRNA-CCAT2 Reduces the Drug Resistance of Ovarian Cancer Cells. Journal of Biomaterials and Tissue Engineering 12:7, pages 1417-1422.
Crossref
Crossref
Chixing Luo, Chuansheng Nie, Yibin Zeng, Kang Qian, Xudong Li & Xuan Wang. (2022) LINC01564 Promotes the TMZ Resistance of Glioma Cells by Upregulating NFE2L2 Expression to Inhibit Ferroptosis. Molecular Neurobiology 59:6, pages 3829-3844.
Crossref
Crossref
Swagatama Mukherjee & Prakash P. Pillai. (2022) Current insights on extracellular vesicle-mediated glioblastoma progression: Implications in drug resistance and epithelial-mesenchymal transition. Biochimica et Biophysica Acta (BBA) - General Subjects 1866:3, pages 130065.
Crossref
Crossref
Tanvi R. Parashar, Febina Ravindran & Bibha Choudhary. 2022. Central Nervous System Tumors. Central Nervous System Tumors.
Małgorzata Grabowska, Julia O. Misiorek, Żaneta Zarębska & Katarzyna Rolle. 2022. Clinical Applications of Non-Coding RNAs in Cancer. Clinical Applications of Non-Coding RNAs in Cancer
17
64
.
Garima Yadav & Ritu Kulshreshtha. (2021) Metastasis associated long noncoding RNAs in glioblastoma: Biomarkers and therapeutic targets. Journal of Cellular Physiology 237:1, pages 401-420.
Crossref
Crossref
Radu Pirlog, Rares Drula, Andreea Nutu, George Adrian Calin & Ioana Berindan-Neagoe. (2021) The Roles of the Colon Cancer Associated Transcript 2 (CCAT2) Long Non-Coding RNA in Cancer: A Comprehensive Characterization of the Tumorigenic and Molecular Functions. International Journal of Molecular Sciences 22:22, pages 12491.
Crossref
Crossref
Xinqi Ge, Ziheng Wang, Rui Jiang, Shiqi Ren, Wei Wang, Bing Wu, Yu Zhang & Qianqian Liu. (2021) SCAMP4 is a novel prognostic marker and correlated with the tumor progression and immune infiltration in glioma. The International Journal of Biochemistry & Cell Biology 139, pages 106054.
Crossref
Crossref
Sara Momtazmanesh & Nima Rezaei. (2021) Long Non-Coding RNAs in Diagnosis, Treatment, Prognosis, and Progression of Glioma: A State-of-the-Art Review. Frontiers in Oncology 11.
Crossref
Crossref
Yeonsoo Chae, Jungwook Roh & Wanyeon Kim. (2021) The Roles Played by Long Non-Coding RNAs in Glioma Resistance. International Journal of Molecular Sciences 22:13, pages 6834.
Crossref
Crossref
Soudeh Ghafouri-Fard, Amin Agabalazadeh, Atefe Abak, Hamed Shoorei, Mohammad Mehdi Hassanzadeh Taheri, Mohammad Taheri & Guive Sharifi. (2021) Role of Long Non-Coding RNAs in Conferring Resistance in Tumors of the Nervous System. Frontiers in Oncology 11.
Crossref
Crossref
Sung-Hyun Kim, Key-Hwan Lim, Sumin Yang & Jae-Yeol Joo. (2021) Long non-coding RNAs in brain tumors: roles and potential as therapeutic targets. Journal of Hematology & Oncology 14:1.
Crossref
Crossref
Parvaneh Mahinfar, Behzad Baradaran, Sadaf Davoudian, Fatemeh Vahidian, William Chi-Shing Cho & Behzad Mansoori. (2021) Long Non-Coding RNAs in Multidrug Resistance of Glioblastoma. Genes 12:3, pages 455.
Crossref
Crossref
Bo Zhang, Qinglin Li, Bin Wu, Shuyuan Zhang, Liwen Li, Kai Jin, Sheng Li, Kai Li, Zeng Wang, Yi Lu, Liang Xia & Caixing Sun. (2021) Long non-coding RNA TP73-AS1 is a potential immune related prognostic biomarker for glioma. Aging 13:4, pages 5638-5649.
Crossref
Crossref